01 January 2003
Extramedullary relapse of acute myeloid leukemia after the second allogeneic stem cell transplantation, manifested as an intussusception of the intestine
Agata Wrzesień-Kuś, Jacek Treliński, Radzisław Kordek, Jerzy Hołowiecki, Tadeusz RobakCase Rep Clin Pract Rev 2003; 4(4):308-311 :: ID: 449676
Abstract
Background: Extramedullary relapses (EMR) after allogeneic stem cell transplantation (alloSCT) occur in up to 20% of patients with acute myelogenous leukemia (AML). However, isolated EMR are rare.
Case report: We present the case of the patient with relapse of acute myeloid leukemia (AML) after 2nd
allogeneic stem cell transplantation (alloSCT), first manifested as an intussusception of an intestine. His peripheral blood and bone marrow examinations at this time were normal. The explorative laparotomy had shown massive infiltration of the small intestine and the root of mesentery with segmental occlusion of the colon due to invagination. Histopathological examination of the biopsy of the intestine revealed the leukemic infiltration. The patient died 3
weeks after the operation as a result of infectious complications and the progression of leukemia.
Conclusion: Timely diagnosis and early re-induction treatment may give a chance for prolonging the life
of some patients in these rare cases of AML with relapse limited to bowel. However the prognosis
of AML relapsed after alloSCT also in the case of isolated EMR is poor and its management is extremely difficult because of cumulative toxicity of the previous intensive treatment.
Keywords: acute myeloid leukemia, Intussusception, allogeneic stem cell transplantation
271
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946215
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946869
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947011
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946427
Most Viewed Current Articles
21 Jun 2024 : Case report
94,176
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
51,416
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
28,562
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,092
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030